1081O ctDNA reduction and clinical efficacy of the darovasertib + crizotinib (daro + crizo) combination in metastatic uveal melanoma (MUM)

Meredith McKean, Bartosz Chmielowski, Marcus O. Butler, R. Carvajal, Jordi Rodón, Matteo S. Carlino, K.B. Kim, Trisha M. Wise‐Draper, Shaheer Khan, April K.S. Salama, Justin C. Moser, James A. Reeves, Keith D. Wilner, Mathew S. Maurer, Masoumeh Abed, Brent Mitchell, Darrin M. Beaupre, Marlana Orloff